Position in ADMA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,080,145
+$422,161 QoQ
Shares Held
248,524
+35.1% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#78
of 321 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Future Fund LLC holds $27,055,231 across 6 Biotechnology names. ADMA ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
142,007 | $11,114,887 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
71,362 | $5,658,292 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
14,704 | $4,647,787 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,037 | $2,502,029 | |
| 5 | ADMA |
Adma Biologics, Inc.
This page
|
248,524 | $2,080,145 | |
| 6 | ARGX |
Argenx SE
|
1,134 | $1,052,091 |
All Filings in ADMA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,080,145 | 248,524 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,657,984 | 184,016 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,777,159 | 97,432 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $939,999 | 64,120 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $731,586 | 40,175 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||